+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Insulin Resistance - Pipeline Insight, 2025 - Product Thumbnail Image

Insulin Resistance - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acromegaly- Pipeline Insight, 2025 - Product Thumbnail Image

Acromegaly- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
ANGPTL3 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ANGPTL3 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Prediabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Prediabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Somatostatin Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Somatostatin Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Severe Hypertriglyceridemia - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Hypertriglyceridemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 70 Pages
  • Global
From
Diabetic Ketoacidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Ketoacidosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Congenital Hyperinsulinism - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Hyperinsulinism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Insulin Like Growth Factor (IGF) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Insulin Like Growth Factor (IGF) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Insulin Like Growth Factor 1 (IGF-1) Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Exocrine Pancreatic Insufficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Semaglutide Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

Semaglutide Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
From
From
From
From
From
Empagliflozin Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Empagliflozin Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more